screen_shot_2012-11-07_at_10

Sanofi’s chief executive new president elect of EFPIA

November 7, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chris Viehbacher, Sanofi

European pharma members body the EFPIA has announced that Sanofi’s chief executive Christopher Viehbacher is to stand as its new …

Takeda HQ image

Takeda to buy Envoy Therapeutics

November 7, 2012
Research and Development, Sales and Marketing CNS, Envoy, Parkinson's, Parkinsons, Takeda

Takeda Pharmaceutical Company has bought another private US firm, its second in as many months. The Japanese group is paying …

Pfizer Sandwich image

Pfizer backs new biotech firm

November 6, 2012
Research and Development, Sales and Marketing Pfizer, Sandwich, Ziarco

Pfizer is one of the main backers of new biotech company Ziarco, launched by four of the manufacturer’s ex-employees. The …

Pharma manufacturing news in brief

November 6, 2012
Manufacturing and Production Cytovance, DSM, Insipiration, Neolpharma, Paranta, Patheon

A round up of recent pharma manufacturing news, including an Ipsen/Inspiration facility up for sale, new contracts for Patheon, Cytovance …

goldrick

First Northern Ireland director for ABPI announced

November 6, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Colette Goldrick, Ireland

The ABPI has confirmed the appointment of Colette Goldrick as its new Northern Ireland director and as a member of …

Astrazeneca image

MRC gives £7 million to new projects

November 6, 2012
Sales and Marketing AstraZeneca, MRC, academics

The Medical Research Council (MRC) has handed out £7 million in funding for 15 research projects which will use a …

lilly image

New plant positions Lilly for changing insulin market

November 6, 2012
Manufacturing and Production Boehringer, insulin, lilly

Eli Lilly has unveiled plans for a $140 million expansion of its insulin plant in Indianapolis as it starts to …

Xarelto image

Further US approval for Xarelto

November 5, 2012
Sales and Marketing Eliquis, FDA, Pradaxa, Xarelto

US regulators have given the go-ahead to expand the indications for which Janssen Pharmaceuticals and Bayer HealthCare’s oral blood thinner …

Bayer to acquire Schiff Nutrition

November 4, 2012
Sales and Marketing Bayer, mergers and acquisitions

Bayer HealthCare is to buy US-based vitamins and nutritional supplements firm Schiff Nutrition International for $1.2 billion.The deal is part …

Pfizer stumbles in third quarter

November 2, 2012
Research and Development, Sales and Marketing Ian Read, Lipitor, Pfizer, Prevnar, Q3

Pfizer has experienced a worse than expected third quarter, due to disappointing sales of paediatric vaccine Prevnar and a surprise …

Sanofi criticised for multiple sclerosis manoeuvres

November 2, 2012
Sales and Marketing Cancer, Lemtrada, MS, Sanofi

Sanofi is facing a backlash as it prepares its new MS treatment for the market. Lemtrada (alemtuzumab) has produced very …

screen_shot_2012-11-02_at_09

COPA-DATA appoints new UK managing director

November 2, 2012
Manufacturing and Production, Research and Development, Sales and Marketing COPA-DATA, Martyn Williams

Ergonomic process solutions firm COPA-DATA has appointed Martyn Williams as UK managing director with immediate effect. A qualified electronic engineer, …

Novartis image

Novartis says Canada and Switzerland lift vaccines ban

November 2, 2012
Manufacturing and Production Canada, Novartis, Switzerland, vaccines

A temporary suspension on the distribution of flu vaccines made by Novartis has been lifted in Canada and Switzerland. The …

yervoy image

NICE hails ‘breakthrough’ skin cancer treatments

November 2, 2012
Sales and Marketing BMS, NICE, Roche, Yervoy, Zelboraf

Two new skin cancer drugs have been recommended by NICE, which hailed the drugs as ‘breakthrough treatments’. Bristol-Myers Squibb’s Yervoy …

Ameridose iamge

Meningitis probe extends to NECC sister company

November 1, 2012
Manufacturing and Production NECC, ameridose, meningitis

A second compounding pharmacy has been drawn into the investigation into the meningitis outbreak that has killed 29 people in …

mikem

Mike Mallinson joins The Access Partnership

November 1, 2012
Medical Communications, Sales and Marketing Mark Mallinson, The Access Partnership

Mike Mallinson has been appointed to lead communications firm The Access Partnership in the role of president. Mallinson is a …

gsk image

GSK hit by European austerity again

November 1, 2012
Sales and Marketing Europe, GSK, Q3, austerity

GlaxoSmithKline suffered in the third quarter as sales fell 5% due to generic competition and austerity measures in Europe.Exceptional sales …

Novartis to build $500 million biotech facility in Singapore

November 1, 2012
Manufacturing and Production, Sales and Marketing Jimenez, M&P, Novartis, Singapore

Novartis is overseeing the construction of a biotechnology facility in Singapore that is the result of a $500m investment injection. …

peter_levantis

Inspired Science appoints principal medical writer

October 31, 2012
Medical Communications, Sales and Marketing Inspired Science, Peter Levantis

Med comms firm Inspired Science has announced the appointment of Dr Peter Levantis as principal medical writer. In this newly …

sanofi image

Diabetes softens generics blow for Sanofi

October 30, 2012
Sales and Marketing Eloxatin, Plavix, Sanofi, diabetes, emerging markets, patent cliff

Sanofi has unveiled its results for the third quarter, with news that the damage done by patent expiries has not …

The Gateway to Local Adoption Series

Latest content